Unveiling hidden neurodegeneration in isolated REM sleep behavior disorder through MRI microstructure and glymphatic

Silvia Basaia1,2, Elisabetta Sarasso1,2,3,4, Andrea Gardoni1,2

  • 1Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

NPJ Parkinson'S Disease
|December 3, 2025
PubMed

Insights

This study reveals early neurodegeneration in isolated REM sleep behavioral disorder (iRBD) patients, showing subtle clinical deficits, brain matter changes, and impaired glymphatic flow. These findings highlight potential early markers for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Radiology
  • Sleep Medicine

Background:

  • Isolated REM sleep behavioral disorder (iRBD) is a prodromal stage for synucleinopathies.
  • Early detection of neurodegeneration and associated functional changes is crucial for understanding disease progression.

Purpose of the Study:

  • To assess microstructural MRI and glymphatic flow alterations in iRBD patients compared to controls.
  • To compare iRBD subgroups based on disease severity.
  • To investigate correlations between clinical symptoms and MRI findings.

Main Methods:

  • 44 iRBD subjects and 52 controls underwent clinical and MRI evaluations.
  • Microstructural alterations in gray and white matter were analyzed.
  • Diffusion-tensor image analysis along the perivascular space (DTI-ALPS) was used to evaluate glymphatic flow.
  • Cluster analysis identified patient subgroups.

Main Results:

  • iRBD subjects exhibited poorer sleep quality, reduced manual dexterity, and gait disturbances.
  • Alterations were observed in the fronto-parietal gray matter and brainstem/frontal white matter.
  • A lower DTI-ALPS index indicated impaired glymphatic function in iRBD patients.
  • Worse gray matter changes correlated with poorer manual dexterity, mobility, and sleep quality.
  • Cluster analysis revealed subgroups with distinct clinical and DTI-ALPS profiles.

Conclusions:

  • iRBD is associated with early neurodegeneration, including microstructural brain changes and impaired glymphatic flow.
  • Subtle clinical deficits correlate with specific MRI findings.
  • The DTI-ALPS index may serve as a biomarker for glymphatic dysfunction in iRBD.